Wednesday was a momentous occasion for the Duquesne University School of Law. It was able to acquire a fifty-million dollar investment from a prominent attorney and graduate named Thomas Kline.
Kline is a well-known personal injury and medical malpractice attorney who represents clients all around the United States, including in the state of Pennsylvania.
He gained widespread respect for taking on and successfully challenging big pharmaceutical companies in numerous high-profile instances.
In 2019, Kline was successful in obtaining a $8 billion judgment against Johnson & Johnson’s Janssen Pharmaceuticals about a medicine that was associated with the abnormal development of breast tissue in young boys.
Kline owes a significant portion of his accomplishments to the education that he had at Duquesne.
The President of Duquesne University, Ken Gormley, said on Wednesday that the money would assist future attorneys who come through the school. The Thomas R. Kline School of Law at Duquesne University is the name that has been given to the 111-year-old law school at Duquesne University in recognition of the tremendous impact that he has made.
